Written and maintained by CASRAI Editorial Board
Published
On this page
Opsite Flexifix is a transparent, moisture-vapour permeable polyurethane adhesive film roll manufactured by Smith & Nephew. It is designed to retain primary dressings, stabilize medical tubing and catheters, and shield intact skin from frictional shear, moisture, and external bacterial contamination.
This page describes products and general use; it is not medical advice.
Short answer
Opsite Flexifix is a non-sterile, cut-to-size polyurethane adhesive film supplied on a continuous roll. It functions as a waterproof, breathable secondary retention dressing and friction barrier. The film allows continuous visual inspection, permits patient showering, resists bacterial ingress, and releases upon gentle horizontal stretching to protect fragile epidermal layers from adhesive trauma.
Definition and scope
Opsite Flexifix is an adhesive medical tape and retention dressing consisting of a thin, conformable polyurethane membrane coated on one side with a hypoallergenic, solvent-free acrylic adhesive. Categorized as a transparent film roll rather than an island dressing, it is packaged in continuous roll formats—most commonly 5 cm × 10 m and 10 cm × 10 m rolls—dispensed non-sterile for external fixation and epidermal shielding.
The clinical scope of Opsite Flexifix encompasses three principal applications across hospital, outpatient, and research settings:
- Secondary dressing retention: Holding primary absorbent pads, alginates, foams, or contact layers securely against the wound bed without the bulk and displacement risk of traditional elastic bandages. Understanding the structural dressing versus bandage distinction is essential when selecting retention materials for contoured anatomical sites.
- Medical device and catheter stabilization: Securing peripheral intravenous catheters, drainage tubes, central line extension sets, and external sensor leads to intact skin, mitigating tension-induced displacement and mechanical catheter migration.
- Intact skin barrier protection: Shielding vulnerable anatomical landmarks (such as heels, elbows, and sacral margins) from shearing forces, friction, and moisture associated with bed linen, orthotic braces, or body fluids. It is also applied to peristomal margins beneath ostomy appliance wafers and leg bag straps to protect skin from moisture-associated skin damage (MASD).
Unlike pre-cut sterile island dressings (such as Opsite Post-Op or dedicated IV site dressings), standard Opsite Flexifix is non-sterile and does not incorporate an absorbent central pad. Consequently, it is not indicated as a direct primary dressing over actively exuding or open full-thickness wounds. Instead, it serves as an outer barrier layer or retention medium, aligning with the operational principles of broader transparent film dressings for wounds across acute and long-term care environments.
How it works or how it is used in practice
The clinical utility of Opsite Flexifix depends on the physical chemistry of its polyurethane backing and the viscoelastic mechanics of its adhesive interface.
1. Semipermeable Membrane Architecture and Fluid Dynamics
The polyurethane membrane in Opsite Flexifix is semipermeable, possessing a high moisture vapour transmission rate (MVTR) benchmarked internationally under standardized test methods such as BS EN 13726-2 (Test methods for primary wound dressings — Part 2: Moisture vapour transmission rate of permeable film dressings). This microscopic polymeric structure allows insensible perspiration and moisture vapour to transpire freely away from the skin surface.
In clinical practice, high moisture vapour permeability prevents fluid accumulation underneath the film. When an impermeable occlusive film traps perspiration, the stratum corneum softens, overhydrates, and undergoes maceration, drastically compromising epidermal barrier function. By allowing controlled vapour diffusion while maintaining a liquid-tight and bacteria-tight barrier, Opsite Flexifix maintains a physiological moisture balance on intact skin. Simultaneously, its continuous exterior surface enables patients to bathe or shower without compromising underlying wound dressings or stabilized lines.
2. Acrylic Adhesive Chemistry vs. Soft Silicone Technology
Standard Opsite Flexifix utilizes a pressure-sensitive, solvent-free acrylic adhesive. Acrylic adhesives achieve high initial grab (tack) and maintain durable tensile retention over multi-day wear cycles, resisting premature edge roll caused by clothing friction or movement. However, because acrylic adhesive forms a rigid microscopic bond with surface corneocytes, improper vertical peeling can tear superficial skin layers, causing Medical Adhesive-Related Skin Injury (MARSI).
To eliminate skin stripping in vulnerable populations—such as neonates, geriatric patients, and individuals on prolonged systemic corticosteroid regimens—Smith & Nephew developed Opsite Flexifix Gentle. This variant incorporates a soft silicone adhesive layer. Silicone adhesives possess low surface tension, allowing them to flow across skin micro-contours without deeply adhering to the stratum corneum. Silicone film rolls can be lifted, repositioned, and removed atraumatically with virtually no epidermal stripping, providing a targeted alternative where fragile skin precludes standard acrylic tapes. For patients presenting with preexisting skin fragility, clinical teams frequently integrate silicone dressings for skin tears into holistic protection protocols.
3. Biophysics of Horizontal Stretch Removal
A frequent error among clinical staff and home caregivers is attempting to pull Opsite Flexifix vertically away from the skin at a 90-degree angle. Vertical removal concentrates mechanical peeling tension directly on the epidermis, maximizing shear stress on the dermal-epidermal junction and causing mechanical blistering or skin tears.
The manufacturer Instructions for Use (IFU) specify a horizontal stretch removal technique:
- The clinician gently lifts one corner of the film.
- The clinician holds the edge and stretches the film horizontally along the skin surface, parallel to the plane of the skin.
- As the polyurethane film stretches elastically, the continuous adhesive layer breaks its mechanical seal along microscopic shear planes, releasing smoothly without pulling the epidermis upward.
This stretch-release dynamic dramatically reduces the peel force required for dressing changes, maintaining skin integrity across repeated applications.
4. Neuropathic Pain Relief and Tactile Shielding
Beyond dressing retention and moisture management, peer-reviewed clinical research has validated Opsite polyurethane film as an effective physical intervention for chronic neuropathic discomfort. In a landmark randomized controlled crossover trial conducted by Foster et al. (Diabetic Medicine, 1994, PMID 7851071), clinicians investigated the application of OpSite film on patients suffering from chronic painful diabetic peripheral neuropathy (DPN).
The study demonstrated a statistically significant reduction in subjective pain scores ($p < 0.001$) and a marked decrease in secondary analgesic consumption (such as paracetamol) among patients with film-covered limbs compared to control intervals. The underlying mechanism is purely physical: painful diabetic neuropathy frequently manifests as cutaneous allodynia and hyperalgesia, where light tactile stimuli (such as ambient air currents, clothing movement, or bedsheets touching the skin) trigger debilitating neuropathic pain paroxysms. Applying a thin polyurethane film creates a tactile shield over sensitized cutaneous nociceptors, isolating superficial nerve endings from mechanical friction and eliminating frictional shear without altering central pharmacological pathways.
5. Clinical Trial and Protocol Applications
In clinical trials and observational research protocols, Opsite Flexifix serves as an essential consumable for maintaining data integrity during longitudinal device monitoring. Investigational wearable biosensors, continuous glucose monitor (CGM) transmitters, skin temperature probes, and actigraphy devices require continuous, motion-resistant skin contact over 7 to 14 days. Opsite Flexifix provides an inert, conformable overlay that stabilizes wearable sensors against sweating and mechanical dislodgement without interfering with radiofrequency transmissions or optical sensor pathways. Furthermore, its complete transparency allows research coordinators to visually verify sensor positioning and inspect skin condition without peeling or compromising the experimental apparatus.
Types or related concepts
Selecting appropriate retention and protective film rolls requires evaluating adhesive type, sterility, moisture handling, and intended anatomical location. The dataset table compiled below details the regulatory and material specifications comparing Opsite Flexifix with alternative film and island dressing formats across adhesive chemistry, sterility, FDA product codes, and CMS HCPCS billing categories.
To assist clinical procurement officers and wound care teams in selecting between standard rolls, gentle silicone variants, and sterile island dressings, the following clinical decision matrix outlines operational selection criteria:
| Clinical Scenario | Recommended Format | Primary Selection Rationale | Key Application Precaution |
|---|---|---|---|
| Secondary Retention on Normal Adult Skin | Opsite Flexifix (Standard Acrylic Roll) | High initial tack and tensile stability resist edge rolling during patient ambulation and showering. | Ensure underlying wound is covered with an appropriate absorbent primary pad; do not apply under tension. |
| At-Risk or Friable Skin (Pediatric, Geriatric, Oncology) | Opsite Flexifix Gentle (Silicone Roll) | Soft silicone flows over micro-contours, allowing repositioning and painless removal without epidermal stripping. | Verify skin is clean and completely dry before application; avoid heavy mechanical pulling on secured lines. |
| Acute Post-Surgical Incision or Suture Line | Opsite Post-Op (Sterile Island Dressing) | Sterile barrier with integrated absorbent pad manages post-operative exudate while preventing bacterial ingress. | Maintain strict aseptic technique during placement; replace when exudate reaches edge of central pad. |
| Wearable Sensor & Research Device Stabilization | Opsite Flexifix (Standard Roll) | Transparent, conformable film provides continuous visual confirmation of sensor contacts and skin status. | Avoid placing film over device battery vents or acoustic ports; remove using horizontal stretch technique. |
When implementing these products in procedural kits or central supply stocks, facilities must observe the strict boundary between sterile versus clean technique. Non-sterile film rolls must never be placed directly into an open sterile surgical field or applied as a primary contact layer over critical intravascular entry sites without an underlying sterile dressing.
Where it matters for labs, clinics or supply decisions
Institutional procurement of Opsite Flexifix impacts clinical efficiency, inventory budgets, regulatory compliance, and Medicare reimbursement workflows across inpatient and outpatient care environments.
1. FDA Regulatory Classification and Product Coding
Under United States Food and Drug Administration (FDA) regulations, Opsite Flexifix is classified as a Class I medical device under 21 CFR § 880.5240 (“Medical adhesive tape and adhesive bandage”). It is categorized under FDA Product Code KGX (Medical Specialty: General Hospital; Device Class: 1). Devices under this regulation are exempt from premarket notification 510(k) submissions under Section 510(l) of the Federal Food, Drug, and Cosmetic Act, provided they do not exceed the generic limitations defined in 21 CFR § 880.9.
Distributors and supply officers must distinguish Product Code KGX from FDA Product Code NAD (21 CFR § 878.4020, “Dressing, Wound, Occlusive”). While Product Code NAD governs pre-cut sterile transparent dressings intended for direct wound application, Product Code KGX regulates adhesive tapes and non-sterile rolls utilized for securement and external coverage. Under Global Unique Device Identification Database (GUDID) records, Smith & Nephew lists Opsite Flexifix under primary Device Identifiers 05000223411466 (5 cm × 10 m roll) and 05000223411473 (10 cm × 10 m roll), explicitly noting commercial status as a non-sterile transparent film roll manufactured without natural rubber latex.
2. CMS HCPCS Billing Nuances and DME MAC Policy
Reimbursement for transparent films and medical tapes under Medicare Part B Durable Medical Equipment (DME) coverage is governed by DME MAC Local Coverage Determination (LCD) L33831 and Policy Article A54563 for Surgical Dressings. Supply managers and billing specialists frequently encounter claim rejections when attempting to bill non-sterile film rolls under sterile dressing codes.
CMS establishes distinct Healthcare Common Procedure Coding System (HCPCS) Level II categories:
- HCPCS A6257, A6258, A6259 (Sterile Transparent Film Dressings): A6257 (16 sq. in. or less), A6258 (more than 16 to 48 sq. in.), and A6259 (more than 48 sq. in.). These codes strictly define sterile, unit-dose transparent film dressings. Under Medicare LCD L33831, coverage requires that the dressing be applied to a “qualifying wound”—specifically a wound caused or treated by a surgical procedure, or a wound debrided by a healthcare professional. Crucially, Policy Article A54563 mandates that claims submitted for codes A6257–A6259 must include an anatomical wound-count modifier (modifiers A1 through A9); claims submitted without wound modifiers are systematically rejected by Medicare claims processing engines.
- HCPCS A4450 and A4452 (Adhesive Tape / Retention Rolls): When non-sterile transparent film rolls like Opsite Flexifix are dispensed for secondary retention, Medicare crosswalks the material to HCPCS code A4452 (“Tape, waterproof, per 18 square inches”) or A4450 (“Tape, non-waterproof, per 18 square inches”). To achieve reimbursement under the surgical dressing benefit, tape must be medically necessary to hold a covered primary dressing in place, and suppliers must append the AW modifier (designating a non-covered primary dressing crosswalk or surgical dressing supply item). Billing non-sterile roll film under sterile unit-dose codes (A6257–A6259) represents a severe coding discrepancy that triggers pre- and post-payment audit clawbacks.
- Non-Covered Prophylactic Use: Medicare surgical dressing benefits do not cover supplies applied to intact skin for pressure injury prophylaxis, blister prevention, or device securement unrelated to a qualifying wound. When Opsite Flexifix is utilized for catheter securement, it is absorbed under institutional global procedure fees or outpatient clinic overhead rather than billed separately under DME surgical dressing codes.
3. Procurement Economics: Roll Formats vs. Unit-Dose Waste
In high-volume hospital wards, burn units, and clinical research facilities, supply logistics favor continuous roll formats over pre-cut dressings. Custom-cutting film from a 10-meter roll allows clinicians to tailor dressing dimensions precisely to contoured anatomical areas or to secure multiple catheter lines simultaneously. This eliminates the financial waste of opening multiple oversized pre-cut sterile sheets. However, supply chain protocols must enforce clean handling at the bedside: because the roll is multi-use, cutting shears must be sanitized between patients, and the outer dispenser box must remain clean to prevent cross-contamination.
4. Critical Care Skin Preservation Protocols
In acute hospital environments, device-related pressure injuries (DRPI) account for a substantial proportion of hospital-acquired complications. As documented by White (British Journal of Nursing, 2013, PMID 24151709), intensive care patients undergoing mechanical ventilation or hemodynamic monitoring experience continuous mechanical friction from endotracheal tube holders, nasal prongs, and monitoring cables. Applying flexible polyurethane film rolls over vulnerable facial and cervical skin creates a sacrificial low-friction interface, absorbing shear stresses before they transmit to the fragile dermis. In cardiothoracic intensive care units, standardizing film barrier protocols has significantly reduced medical adhesive-related skin injuries (MARSI) and epidermal breakdown.
Common misunderstandings
Clinical audits and supply reviews identify several recurring errors in how Opsite Flexifix is managed and applied:
- Misunderstanding: Opsite Flexifix can be used as a primary dressing on heavily draining wounds.
Fact: Opsite Flexifix has no absorbent capacity. Placing an adhesive film directly over a moderate-to-heavy exuding wound causes fluid to pool beneath the membrane, leading to rapid skin maceration, dressing leakage, and increased bacterial proliferation. It must only be used as a primary dressing over dry, minimally exuding superficial wounds, or as a secondary retention layer over an absorbent primary dressing (such as calcium alginate, foam, or gauze). - Misunderstanding: Non-sterile Opsite Flexifix rolls can replace sterile dressings on central line insertion sites.
Fact: While Opsite Flexifix provides an impermeable bacterial barrier, the roll itself is non-sterile. Central venous catheter (CVC) insertion sites and peripherally inserted central catheter (PICC) sites mandate sterile, dedicated IV securement dressings applied using strict aseptic technique. Opsite Flexifix may be used to secure distal tubing on intact skin away from the puncture site, but never directly over an open intravascular insertion site. - Misunderstanding: The film should be stretched tautly during application to ensure good adhesion.
Fact: Applying transparent polyurethane film under tension is a leading cause of traction blistering and mechanical shear injury. When stretched across skin, the elastic polyurethane constantly tries to contract back to its resting state, exerting chronic shear tension on the epidermis. Opsite Flexifix must always be laid down smoothly and unstretched, followed by gentle smoothing from the center outward. - Misunderstanding: Waterproof dressings completely block skin breathing.
Fact: The polyurethane membrane in Opsite Flexifix is semipermeable, not occlusive. It blocks liquid water droplets and bacteria (which are thousands of times larger than polymer intermolecular gaps) while allowing individual water vapour molecules to pass freely. This high moisture vapour transmission rate prevents sweat accumulation while maintaining liquid barrier integrity. - Misunderstanding: Removing the dressing quickly like athletic tape minimizes patient pain.
Fact: Rapid vertical peeling tears the stratum corneum and inflicts severe skin stripping. Opsite Flexifix should be removed using horizontal extension (stretching the film parallel to the skin surface), which smoothly disengages the adhesive matrix.
FAQ
Can Opsite Flexifix be applied directly over an open wound?
No. Standard Opsite Flexifix is supplied as a non-sterile roll and contains no absorbent pad. It is not intended as a direct primary contact layer for exuding, infected, or deep open wounds. For open wounds, an appropriate sterile primary dressing (such as an alginate, hydrogel, or foam pad) must be placed on the wound bed first, with Opsite Flexifix used strictly as a secondary retention layer over the surrounding healthy, intact skin.
Can patients shower with Opsite Flexifix in place?
Yes. Opsite Flexifix forms an impermeable barrier to liquid water and external bacteria. When applied properly with all edges smoothed flat against clean, dry, oil-free skin, patients can shower without water penetrating the film or loosening the underlying dressing. However, prolonged soaking in baths, hot tubs, or swimming pools is not recommended, as heat and extended water submersion can weaken adhesive bonds.
How does Opsite Flexifix Gentle differ from standard Opsite Flexifix?
Standard Opsite Flexifix utilizes a hypoallergenic acrylic adhesive that provides strong, durable adhesion over extended wear times, ideal for general retention on normal adult skin. Opsite Flexifix Gentle incorporates a soft silicone adhesive specifically formulated for friable, elderly, neonatal, or compromised skin. The silicone adhesive allows gentle, repositionable application and painless removal without causing epidermal stripping or skin tears.
How should Opsite Flexifix be removed to prevent skin tears?
To remove Opsite Flexifix safely, gently lift one corner of the dressing. Rather than pulling the film upward away from the body, stretch the film horizontally along the surface of the skin, parallel to the body contour. This horizontal stretching elongates the polyurethane membrane, breaking the adhesive bond cleanly without pulling or tearing the underlying epidermis.
What HCPCS code is used when billing Opsite Flexifix to Medicare?
Under Medicare DME MAC Surgical Dressing guidelines (LCD L33831 and Policy Article A54563), non-sterile transparent film retention rolls are classified under HCPCS code A4452 (Tape, waterproof, per 18 sq. in.) with modifier AW, when used to secure a covered surgical dressing. They must not be billed under sterile unit-dose codes A6257–A6259 (which require qualifying debrided wounds and wound modifiers A1–A9), nor are they covered when used solely for intact skin protection or device stabilization.
How long can Opsite Flexifix remain in place?
In general clinical practice, Opsite Flexifix can remain in place for up to 7 days, depending on the volume of underlying wound drainage, skin perspiration, and condition of the edges. The dressing should be inspected daily through its transparent surface and changed immediately if fluid pools underneath, if edges begin to roll or lift, or if the underlying primary dressing requires routine replacement.
Sources
- U.S. Food and Drug Administration (FDA) — 21 CFR § 880.5240 (“Medical adhesive tape and adhesive bandage”), Product Code KGX, Class I 510(k) exempt. Read 2026-11-12 via https://www.law.cornell.edu/cfr/text/21/880.5240 and https://api.fda.gov/device/classification.json.
- FDA Global Unique Device Identifier Database (AccessGUDID) — Smith & Nephew Medical Limited, OPSITE FLEXIFIX Transparent Film Roll, Primary DI 05000223411466 (5 cm × 10 m), 05000223411473 (10 cm × 10 m). Read 2026-11-12 via https://api.fda.gov/device/udi.json.
- Centers for Medicare & Medicaid Services (CMS) — Medicare DME MAC Local Coverage Determination (LCD) L33831 and Policy Article A54563 (“Surgical Dressings – Policy Article”), HCPCS codes A6257-A6259, A4450, A4452. Read 2026-11-12 via https://www.cms.gov/medicare-coverage-database/view/article.aspx?articleid=54563.
- Smith & Nephew Medical Limited — OPSITE FLEXIFIX and OPSITE FLEXIFIX Gentle Technical Specifications and Instructions for Use (IFU). Read 2026-11-12 via https://www.smith-nephew.com/.
- Foster AV, Eaton C, McConville DO, Edmonds ME. — “Application of OpSite film: a new and effective treatment of painful diabetic neuropathy.” Diabetic Medicine. 1994 Oct; 11(8): 768-772. PMID: 7851071. Read 2026-11-12 via https://pubmed.ncbi.nlm.nih.gov/7851071/.
- White R. — “OPSITE Flexifix Gentle: preventing breakdown in vulnerable skin.” British Journal of Nursing. 2013 Jun 27-Jul 10; 22(12): S32-S35. PMID: 24151709. Read 2026-11-12 via https://pubmed.ncbi.nlm.nih.gov/24151709/.
- British Standards Institution (BSI) — BS EN 13726-2 (“Test methods for primary wound dressings — Part 2: Moisture vapour transmission rate of permeable film dressings”). Read 2026-11-12 via https://www.standardsinfo.net/.
Data: Medical Retention Films and Transparent Dressings: Technical and Regulatory Specifications
Technical comparison of medical adhesive retention films and sterile transparent dressings compiled from manufacturer technical specifications, FDA classification regulations (21 CFR 880 and 878), and CMS DME MAC coding guidelines.
Period covered: 2026. Coverage: United States.
| Product or Format | Adhesive Polymer | Sterility Format | FDA Regulation | FDA Product Code | HCPCS Code |
|---|---|---|---|---|---|
| Opsite Flexifix (Standard) | Solvent-free acrylic | Non-sterile roll | 21 CFR § 880.5240 | KGX | A4452 |
| Opsite Flexifix Gentle | Soft silicone | Non-sterile roll | 21 CFR § 880.5240 | KGX | A4452 |
| Opsite Post-Op | Hypoallergenic acrylic | Sterile unit pouch | 21 CFR § 878.4020 | NAD | A6257-A6259 |
| Tegaderm Roll (3M) | Acrylate copolymer | Non-sterile roll | 21 CFR § 880.5240 | KGX | A4452 |
Sources
- FDA 21 CFR § 880.5240 Medical adhesive tape and adhesive bandage (accessed 2026-11-12)
- FDA 21 CFR § 878.4020 Dressing, wound, occlusive (accessed 2026-11-12)
- FDA openFDA Classification Database (accessed 2026-11-12)
- CMS DME MAC Surgical Dressings Policy Article A54563 (accessed 2026-11-12)
- Smith & Nephew Opsite Flexifix Technical Data (accessed 2026-11-12)
Compiled by CASRAI from the sources above. Free to reuse under CC BY 4.0 with attribution.







